Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-028)

Clinical trial NCT03848065 · COMPLETED

Trial details

NCT number: NCT03848065
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumococcal Infections

Start date: 2019-04-02
Primary completion: 2020-06-24
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.